Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2001, p. 3137-3143, Vol. 21, No. 9
Howard Hughes Medical Institute, Department
of Biochemistry, St. Jude Children's Research Hospital, Memphis,
Tennessee 38105
Received 1 December 2000/Returned for modification 22 January
2001/Accepted 1 February 2001
Gadd45 Elucidating the molecular mechanisms
of interleukin-2 (IL-2)-driven T-cell proliferation is critical to
understanding the regulation of the immune system. The signaling
pathways emerging from the IL-2 receptor require Jak3 and Jak1, two
members of the JANUS family of tyrosine kinases (Jak), which bind to
and phosphorylate the IL-2 receptor as well as substrates recruited to
the receptor complex. Among the substrates are Stat5a and Stat5b
(signal transducer and activator of transcription), both of which are
phosphorylated and translocated to the nucleus where they activate gene
transcription (reviewed in references 8 and 9). Mice
lacking either Jak3 or both Stat5a and Stat5b (Stat5a/b) have revealed
their essential function for IL-2-induced T-cell proliferation
(13, 15). In an attempt to delineate the IL-2 signaling
pathway downstream of Stat5a/b in T cells, we screened a subtracted
cDNA library for Stat5 target genes. Applying representational
difference analysis (RDA) and subsequent Northern blot analysis of
activated wild-type versus Stat5a/b double knockout splenocytes, we
were able to identify IL-2-inducible, Stat5-dependent genes. Among the
clones obtained was the murine gene of Gadd45 In addition to Gadd45 Individual Gadd45 family members are characterized by specific
inducible patterns of expression (reviewed in reference
12). Gadd45 Construction of the Gadd45
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.9.3137-3143.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Gadd45
Is Dispensable for Normal Mouse
Development and T-Cell Proliferation
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, a family member of the growth arrest and DNA
damage-inducible gene family 45 (Gadd45), is strongly induced by
interleukin-2 (IL-2) in peripheral T cells. While in most tissues all
Gadd45 family members are expressed, Gadd45
is the only member that is induced by IL-2. Here we show that the IL-2-induced expression of
Gadd45
is dependent on a signaling pathway mediated by the tyrosine
kinase Jak3 and the transcription factors Stat5a and Stat5b (signal
transducer and activator of transcription). Previous studies with
ectopically overexpressed Gadd45
in various cell lines implicated
its function in negative growth control. To analyze the physiological
role of Gadd45
we used homologous recombination to generate mice
lacking Gadd45
. Gadd45
-deficient mice develop normally, are
indistinguishable from their littermates, and are fertile. Furthermore,
hematopoiesis in mice lacking Gadd45
is not impaired and
Gadd45
-deficient T lymphocytes show normal responses to IL-2. These
data demonstrate that Gadd45
is not essential for normal mouse
development and hematopoiesis, possibly due to functional redundancy
among the Gadd45 family members. Gadd45
is also dispensable for
IL-2-induced T-cell proliferation.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
, which shows 97%
identity at the amino acid level to its human counterpart
(20). This gene had been previously identified by several
approaches, including as an activator of MEKK4/MTK1 (17),
an IL-2-induced immediate-early gene (cytokine response gene 6 [CR6])
(3), an oncostatin M-inducible gene (OIG37)
(14), a gene induced by depletion of neurotrophic factor
in PC12 neuronal cells (11), and a gene coding for a Gadd-related protein of 17 kDa (GRP17) (16).
, the Gadd45 family (growth arrest and DNA
damage-inducible gene family) consists of Gadd45
and
Gadd45
, whose murine isoform is also designated MyD118
(1, 5). Gadd45
shows high sequence similarity to
Gadd45
and Gadd45
at the amino acid level (68 and 70%,
respectively). All Gadd45 family members are small, acidic proteins
that are expressed to different degrees in all tissues
(14). Overexpression of any of the family members in
various cell lines leads to association with proliferating cell nuclear
antigen and p21, a cyclin-dependent kinase inhibitor, and results in
growth suppression (4, 14). These findings led to
the hypothesis that Gadd45 members play a critical role in
negative growth control.
is induced in a p53-dependent manner by
irradiation (10). Gadd45
is upregulated by transforming
growth factor
, which induces growth arrest and apoptosis in the
myeloid cell line M1 (1). Moreover, both Gadd45
and
Gadd45
are induced by IL-6, a differentiation-inducing cytokine, and
by DNA-damaging agents such as methyl methanesulfonate (MMS)
(19). In contrast to the inducible expression pattern of
Gadd45
and Gadd45
associated with growth arrest, differentiation,
and apoptosis, Gadd45
has been shown to be induced in the
proliferative response of T cells to IL-2 (3, 20). This
finding led to the hypothesis that IL-2 also mediates negative growth
control elements such as Gadd45
to ensure proper cell cycling and
genomic stability (20). On the other hand, it could be
hypothesized that Gadd45
supports growth promotion when expressed at
physiological levels. In order to elucidate the physiological function
of Gadd45
, we generated Gadd45
-deficient mice by using targeted
gene disruption. Here, we show that Gadd45
is dispensable for normal
mouse development, hematopoiesis, and in particular, IL-2-driven T-cell proliferation.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
targeting vector and generation of
mutant mice.
A Gadd45
genomic clone was isolated from a 129SV/J
mouse genomic library (Genome Systems Inc.). An 8-kb genomic
EcoRI fragment containing all four exons coding for
Gadd45
was used to construct a targeting vector. A 2-kb
BstEI fragment encompassing most of the coding region was
replaced with a neomycin-resistance gene driven by the thymidine kinase
promoter. This strategy led only the first 13 amino acids of intact
Gadd45
to be translated, which, however, will not give rise to a
stable product. A cDNA coding for the diphtheria toxin A driven by the
thymidine kinase promoter (2) was then cloned 3' of the
genomic sequence to facilitate negative selection.
Northern blot analysis.
Whole-cell RNA was prepared using
the RNAzol B reagent (Tel-Test) according to the directions of the
manufacturer. For Northern blotting, 20 µg of RNA per lane was run on
a 1% formaldehyde agarose gel and blotted onto nitrocellulose
membranes. The cDNAs of Gadd45
, Gadd45
, and Gadd45
, all cloned
from mouse tissues, as well as the cDNAs from
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and gamma interferon
(IFN
) were used as probes, which were labeled by using a random
priming kit (readyprime; Amersham).
JNK kinase assay.
Cells were lysed in
radioimmunoprecipitation assay (RIPA) buffer, and cell debris was
removed by centrifugation. Supernatants were incubated with JNK1
antisera (sc-474; Santa Cruz) for 2 h at 4°C. The immune
complexes were precipitated with protein A agarose (Roche) and washed
twice with RIPA buffer and twice with JNK kinase buffer (10 mM
MgCl2, 50 mM Tris-HCl [pH 7.4], 5 mM benzamidine, 0.5 mM
dithiothreitol, 1 mM sodium vanadate). The kinase reaction was
performed in kinase buffer supplemented with 5 µCi of
[
-32P]ATP, 0.1 mM ATP, and glutathione
S-transferase (GST)-c-Jun(1-135) as a substrate for 20 min
at 30°C. Proteins were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis and blotted onto supported
nitrocellulose membranes. After autoradiography, the membranes were
probed with JNK1 antisera (sc-474; Santa Cruz) and subsequently with
horseradish peroxidase-conjugated anti-rabbit immunoglobulin G. To
visualize the proteins, a standard enhanced chemiluminescence reaction
was employed (ECL; Amersham).
Bone marrow colony assays.
Bone marrow cells were prepared
from tibia and femur in
-MEM medium (Life Technologies) containing
2% fetal calf serum (StemCell Technologies) mixed with cytokines and
MethoCult M3230 (StemCell Technologies) giving a final concentration of
0.9% methylcellulose. For the assays the following cytokines were
used: recombinant human erythropoietin (Epo) (Amgen), recombinant
murine IL-3, IL-6, stem cell factor (SCF), and granulocyte-macrophage
colony-stimulating factor (GM-CSF) (R&D Systems), as well as
recombinant human thrombopoietin (TPO) (Genzyme). Cultures were plated
in 35-mm culture dishes in duplicates and cultured at 37°C. The assay
conditions were described previously (18).
Growth curve and proliferation response assays.
A
single-cell suspension, prepared from spleen and lymph nodes, was
stimulated with 2 µg of anti-CD3 (2C11; PharMingen)/ml and 500 U of
recombinant human IL-2 (Chiron)/ml in RPMI 1640 media (Life
Technologies) supplemented with 10% fetal calf serum,
L-glutamine, penicillin, streptomycin, sodium pyruvate,
essential and nonessential amino acids (all from Life Technologies),
and
-mercaptoethanol (Sigma). To determine the growth curve of T
cells, cells were kept in IL-2-containing media and were split when
they reached a cell density above 106/ml. Viable cell
counts were determined by trypan blue staining every 48 h. Cell
cycle arrest of the growing T-cell culture was achieved by IL-2
withdrawal for 20 h and confirmed by propidium iodide DNA staining.
Staining of cells with Annexin V. Approximately 5 × 105 cells were washed with phosphate-buffered saline, resuspended in 100 µl of binding buffer (10 mM HEPES, 0.9% NaCl, 2.5 mM CaCl2, 0.1% bovine serum albumin) containing 2 µl of Annexin V-Fluos (Annexin V bound to fluorescein isothiocyanate; Roche) and 1 µg of propidium iodide/ml, and incubated at room temperature for 15 min in the dark. The samples were analyzed on a Becton Dickinson FACScan flow cytometer (Becton Dickinson, San Jose, Calif.), collecting green fluorescence from bound Annexin V-fluorescein isothiocyanate molecules and red fluorescence from propidium iodide-DNA complexes in dead cells.
Irradiation and determination of the mitotic index.
Splenocytes were stimulated with anti-CD3 (2 µg/ml) and grown in
IL-2-containing medium (200 U/ml) for 4 days. At this time the doubling
time of the lymphocytes is approximately 16 h. Cells were then
subjected to UV or
irradiation. To determine the mitotic index,
cells were incubated in 75 mM KCl for 15 min and fixed with
methanol-acetic acid fixative. Cells were dropped on microscope slides
and stained with Giemsa stain. Cells with condensed chromosomes were
scored as mitotic cells.
| |
RESULTS |
|---|
|
|
|---|
IL-2-induced Gadd45
transcription is Stat5 and Jak3
dependent.
In screening for IL-2-induced genes by RDA
(6), we identified one clone which hybridized with two
transcripts of 1.4 and 4 kb in IL-2-activated T cells (Fig.
1). Sequence analysis and a similarity
search in GenBank identified this clone as the murine homolog of
Gadd45
, also designated CR6 (17, 20). The closest related genes to Gadd45
are Gadd45
and Gadd45
, which, as
illustrated in Fig. 1, are not regulated in T cells upon activation.
Gadd45
is also induced in primary splenic T cells activated by
anti-CD3 and IL-2, but not in Stat5a/b-deficient T cells (Fig.
2, lanes 1 to 10), which have normal
T-cell receptor signaling but fail to proliferate in response to IL-2
(13). Gadd45
expression could be reconstituted in
Stat5a/b-deficient T cells transduced by a retrovirus carrying the
wild-type Stat5a gene (Fig. 2, lanes 11 to 13), demonstrating that the
impaired Gadd45
induction is due to the lack of Stat5. Since
Stat5a/b activation by IL-2 is dependent on the tyrosine kinase Jak3,
we compared Gadd45
induction in wild-type versus Jak3-deficient
splenocytes. As shown in Fig. 2 (lanes 14 to 23), Gadd45
transcription is not elevated in Jak3-deficient splenocytes treated
with anti-CD3 and IL-2. These data demonstrate that IL-2-induced
Gadd45
expression in peripheral T cells is dependent on signaling
through Jak3 and Stat5a/b and that T cells uniquely express Gadd45
among the Gadd45 family of genes.
|
|
Generation of Gadd45
-deficient mice.
To assess the
physiological function of Gadd45
we generated Gadd45
-deficient
mice. In the targeting construct most of the coding sequence was
replaced by a neomycin resistance gene cassette (Fig.
3A) in order to generate a null mutation.
Out of five homologous recombinant ES cell clones, two clones gave rise
to germ line-transmitted mutant mouse strains as confirmed by Southern
blot and PCR (Fig. 3B and C). Heterozygous mice of both lines were
crossed to examine the phenotype caused by Gadd45
deficiency.
Intercrosses in both mouse lines gave birth to homozygous mutant
Gadd45
mice that were indistinguishable from their wild-type
littermates and were fertile and viable for at least 1 year.
|
-deficient T cells
showed that neither transcript of Gadd45
was detectable (Fig. 3D).
Histological analysis of organs in which Gadd45
is highly expressed,
such as liver and kidney, revealed no abnormalities in Gadd45
null
mice (data not shown). The cellularity of hematopoietic tissues (bone
marrow, thymus, spleen, and lymph nodes) and peripheral blood as well
as the appearance of progenitor and mature T and B cells, NK cells,
macrophages, granulocytes, and erythrocytes were comparable to
wild-type littermates (data not shown). These data show that Gadd45
is not essential for normal mouse development and hematopoiesis.
Cytokine response of Gadd45
-deficient bone marrow cells.
Gadd45
expression is induced by several cytokines, including IL-3,
IL-6, and GM-CSF (20). Based on distinct expression patterns of the three Gadd45 family members, specific functions for
each family member have been proposed. We, therefore, analyzed the
contribution of Gadd45
to the cytokine response of bone marrow cells. As shown in Table 1, Gadd45
is
dispensable for the ability of bone marrow cells to form colonies in
response to IL-3, IL-6, SCF, Epo, TPO, and GM-CSF.
|
Ability of Gadd45
-deficient T lymphocytes to proliferate.
Since Gadd45
is strongly induced by IL-2 in peripheral T cells, we
investigated the proliferative abilities of Gadd45
-deficient T
cells. For these studies, splenocytes were activated with anti-CD3 and
IL-2 or IL-4 or without the addition of cytokine. Thereby, anti-CD3
stimulation activates all T cells, the addition of IL-4 favors the T
helper 2 subset of CD4-positive T cells, and the presence of IL-2
favors CD8-positive T-cell subsets. The cell numbers of the growing
cultures were monitored every 48 h. No differences were evident
between wild-type and Gadd45
-deficient T cells (data not shown).
Irrespective of their genetic background, activated T cells
proliferated in the presence of IL-2 for 14 to 18 days and exponential
growth occurred between day 4 and day 9 (Fig.
4A). During this period the doubling
times of the T-cell cultures from +/+, +/
, and
/
Gadd45
mice
from three independent experiments were 17.6 ± 1.4 h,
18.5 ± 2.7 h, and 18.0 ± 2.3 h, respectively. A
slightly increased cell density of the Gadd45
-deficient T cells was
observed in the late phase of some experiments; however, wild-type as
well as Gadd45
-deficient cells stopped cycling after a comparable
time in culture (Fig. 4A). Moreover, after 4 days the numbers of CD4-
and CD8-positive T cells were similar in cultures of wild-type and
Gadd45
-deficient T cells (data not shown). To investigate the
contribution of Gadd45
to the ability of cultured T cells to arrest
in the G1 phase after withdrawal of IL-2 and reenter the
cell cycle after IL-2 restimulation, cultured T cells grown in the
presence of IL-2 for 7 days were starved and restimulated with IL-2.
Cell cycle analysis of growth-arrested and then IL-2-restimulated cells
over a period of 6 to 25 h after stimulation was performed by
propidium iodide staining of DNA. There was no significant difference
between wild-type and knockout T cells with respect to growth arrest
and IL-2-regulated cell cycle progression (data not shown). In
addition, proliferation in response to increasing IL-2 concentrations
was measured by thymidine incorporation. Fig. 4B illustrates that the
proliferative response of cell cycle-arrested T cells from wild-type
and Gadd45
-deficient mice to increasing amounts of IL-2 was not
statistically different. In order to exclude compensatory upregulation
of Gadd45
and/or Gadd45
in Gadd45
-deficient T cells, the
expression of all three family members was analyzed by Northern
blotting (Fig. 4C) and demonstrated the absence of upregulation of the
other family members. Finally, as measured by Annexin V staining, the
number of apoptotic cells did not differ between wild-type and
Gadd45
-deficient T cells (Fig. 4D).
|
JNK activity in Gadd45
-deficient T lymphocytes.
Gadd45
family members have been implicated in controlling the activity of the
Jun N-terminal kinase, JNK, via binding to the ubiquitously expressed
protein kinase MTK1/MEKK4 (17). The binding of Gadd45
to MTK1/MEKK4 is thought to activate the kinase activity of MTK1, which
in turn activates MEKK3 and MEKK6, upstream activators of JNK. We
investigated the JNK activity in wild-type T cells cultured for 4 days
in the presence of IL-2, at which time they expressed high levels of
Gadd45
. Comparison with Gadd45
-deficient T cells cultured under
the same conditions revealed no difference between the basal levels of
JNK activities (Fig. 5). In addition, anisomycin-stimulated JNK activity is not altered in
Gadd45
-deficient T cells (Fig. 5), demonstrating that Gadd45
is
dispensable for JNK activity.
|
Checkpoint activation and genomic stability in Gadd45
-deficient
T lymphocytes.
Since the Gadd45 family members have been
implicated in genomic stability, we initially examined T cells that had
been expanded for 14 days in culture for karyotypic abnormalities.
Examination of 60 cells failed to identify any abnormal karyotypes
(data not shown). Gadd45
-deficient lymphocytes have been shown to
have defects in the cell cycle checkpoint activation after UV
irradiation (7). Since Gadd45
is uniquely induced by
IL-2 in proliferating T cells, we wished to examine the potential
contribution of this induction to G2M arrest of UV or
-irradiated cells. For these studies, T lymphocytes from wild-type
and Gadd45
-deficient mice were expanded in vitro in the presence of
IL-2 to allow the accumulation of Gadd45
in the wild-type cells. As
illustrated (Fig. 6), there were no
differences between wild-type and Gadd45
-deficient T cells in the
induction of G2M arrest in response to increasing doses of
either UV, as a DNA damaging agent, or
irradiation, as a DNA
double-strand break-inducing agent. Therefore, IL-2-induced expression of Gadd45
in T cells is not essential for genomic stability or cell cycle arrest under the conditions examined.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this report we demonstrate that IL-2 stimulation of T cells
leads to the induction of Gadd45
in a Jak3- and Stat5-dependent manner. However, in contrast to Stat5, loss of Gadd45
does not affect T-cell activation and proliferation. There are three possible explanations for the lack of any consequences. First, although Gadd45
and Gadd45
were not induced in IL-2-stimulated T cells, we
cannot exclude compensation by another, unidentified member of the
Gadd45 family with function overlapping that of Gadd45
. However,
this is unlikely since exhaustive searchs of murine or human expressed
sequences, as well as sequencing the clones identified in our RDA
screen, have failed to identify another family member. The second
possibility is that critical functions mediated by Gadd45
are
redundantly provided by another, unrelated gene product. The third
possibility is that the Stat5a/b-regulated expression of Gadd45
and
the functional consequences are not critical for T-cell proliferation
under the conditions examined.
A number of genes have been identified that are induced with the
activation of peripheral T cells, and many of these are not induced in
Stat5a/b-deficient lymphocytes. For example, cyclin D2 and D3 are not
expressed in Stat5-deficient T cells (13). In order to
test the possibility that Gadd45
is required for their expression,
we examined the expression of D-type cyclin mRNAs and proteins in
activated Gadd45
-deficient T cells. Both cyclin D2 and D3 were
upregulated normally in Gadd45
null splenocytes when stimulated with
anti-CD3 and IL-2 (data not shown).
The dependence on Stat5a/b for Gadd45
expression in T cells and the
reported requirement for Stat3 for the induction of Gadd45
in
myeloid cells would suggest that Stat binding sites exist in the
promoter and mediate the induction (14). However, we have not found any putative Stat binding sites in the promoter sequence spanning 1 kb upstream of the putative TATA box nor in intronic sequences. It is possible that Stat transcription factors act on
enhancer elements further upstream of the gene or indirectly. The lack
of any consequence of deleting Gadd45
might suggest that,
irrespective of the mechanism, the induction of Gadd45
may occur
fortuitously because the gene shares genomic elements that are required
for Stat5a/b regulation of a gene that is critical for T-cell function.
Since the identification of Gadd45
, considerable effort has been
invested in elucidating its functions including overexpression studies
of Gadd45
in diverse cell lines. One function of Gadd45
, deduced
from such studies, is the activation of MEKK4 in response to
MMS-induced cell death of ML-1 cells and the subsequent activation of
JNK and p38 MAPKs (17). This prompted the authors to
speculate the pathway Gadd45
MEKK4
p38/JNK, leading to
apoptosis (17). However, other groups have not detected
significant induction of Gadd45
after MMS treatment in M1 cells
(20) or in NIH-3T3 cells (14). In addition,
we found no evidence that MMS induces Gadd45
expression in T cells.
Irrespective of that, neither the basal nor anisomycin-stimulated JNK
activity is altered in Gadd45
-deficient T cells (Fig. 5),
demonstrating that Gadd45
is dispensable for JNK activity.
The consequences of the overexpression of Gadd45
have been variably
reported to either induce apoptosis in HeLa cells (17) or
not induce apoptosis but rather to reduce the growth rate of HeLa cells
or NIH-3T3 and BaF3 cells (4, 14). In this regard, the
percentage of apoptotic cells in cultures of proliferating Gadd45
-null T cells is neither reduced nor enhanced in comparison to
wild-type T cells (Fig. 4D). Nor is there any indication of a
difference in the proliferative capacity, either increased or decreased, of Gadd45
-deficient T cells. Therefore it is likely that
the overexpression studies have not provided completely accurate information regarding the functions of Gadd45
in cell growth and
apoptosis regulation.
Taken together, our results show that the Stat5a/b-regulated gene,
Gadd45
, is dispensable for T-cell function and, in general, demonstrate that the identification of a target gene does not necessarily mean that the target gene mediates an essential function. More generally, Gadd45
is not required for hematopoiesis or for normal development. The existence of two additional family members raises the possibility that they function redundantly to Gadd45
in
some critical cell lineages. As with many gene families, it will be
important to generate strains of mice that lack two or all of the
family members to explore the possibility of redundancy.
| |
ACKNOWLEDGMENTS |
|---|
We thank John Raucci and Christie Nagy for injection of ES cells into blastocytes as well as Neena Carpino and Richard Ashmun for FACS analysis and Linda Snyder and Kristen Rothammer for technical support. We also thank John Cleveland, Gery Zambetti, Veronika Sexl, Nick Carpino, Christopher Duntsch, Demin Wang, and Jean-Chris Marine for helpful discussion.
This work was supported by the Cancer Center CORE grant CA21765, by grants RO1 DK42932 and PO1 HL53749, and by the American Lebanese Syrian Associated Charities (ALSAC).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Howard Hughes Medical Institute, Department of Biochemistry, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105. Phone: (901) 495-3420. Fax: (901) 525-8025. E-mail: James.Ihle{at}stjude.org.
Present address: Research Institute of Molecular Pathology,
A-1030 Vienna, Austria.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Abdollahi, A., K. A. Lord, B. Hoffman-Liebermann, and D. A. Liebermann. 1991. Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines. Oncogene 6:165-167[Medline]. |
| 2. | Adachi, M., S. Suematsu, T. Kondo, J. Ogasawara, T. Tanaka, N. Yoshida, and S. Nagata. 1995. Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver. Nat. Genet. 11:294-300[CrossRef][Medline]. |
| 3. |
Beadling, C.,
K. W. Johnson, and K. A. Smith.
1993.
Isolation of interleukin 2-induced immediate-early genes.
Proc. Natl. Acad. Sci. USA
90:2719-2723 |
| 4. | Fan, W., G. Richter, A. Cereseto, C. Beadling, and K. A. Smith. 1999. Cytokine response gene 6 induces p21 and regulates both cell growth and arrest. Oncogene 18:6573-6582[CrossRef][Medline]. |
| 5. |
Fornace, A. J., Jr.,
I. Alamo, Jr., and M. C. Hollander.
1988.
DNA damage-inducible transcripts in mammalian cells.
Proc. Natl. Acad. Sci. USA
85:8800-8804 |
| 6. | Frazer, J. K., V. Pascual, and J. D. Capra. 1997. RDA of lymphocyte subsets. J. Immunol. Methods 207:1-12[CrossRef][Medline]. |
| 7. | Hollander, M. C., M. S. Sheikh, D. V. Bulavin, K. Lundgren, L. Augeri-Henmueller, R. Shehee, T. A. Molinaro, K. E. Kim, E. Tolosa, J. D. Ashwell, M. P. Rosenberg, Q. Zhan, P. M. Fernandez-Salguero, W. F. Morgan, C. X. Deng, and A. J. Fornace, Jr. 1999. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23:176-184[CrossRef][Medline]. |
| 8. | Ihle, J. N. 1995. Cytokine receptor signalling. Nature 377:591-594[CrossRef][Medline]. |
| 9. | Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331-334[CrossRef][Medline]. |
| 10. | Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71:587-597[CrossRef][Medline]. |
| 11. | Kojima, S., K. Mayumi-Matsuda, H. Suzuki, and T. Sakata. 1999. Molecular cloning of rat GADD45gamma, gene induction and its role during neuronal cell death. FEBS Lett. 446:313-317[CrossRef][Medline]. |
| 12. | Liebermann, D. A., B. Hoffman, and R. A. Steinman. 1995. Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11:199-210[Medline]. |
| 13. | Moriggl, R., D. J. Topham, S. Teglund, V. Sexl, C. McKay, D. Wang, A. Hoffmeyer, J. van Deursen, M. Y. Sangster, K. D. Bunting, G. C. Grosveld, and J. N. Ihle. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249-259[CrossRef][Medline]. |
| 14. |
Nakayama, K.,
T. Hara,
M. Hibi,
T. Hirano, and A. Miyajima.
1999.
A novel oncostatin M-inducible gene OIG37 forms a gene family with MyD118 and GADD45 and negatively regulates cell growth.
J. Biol. Chem.
274:24766-24772 |
| 15. |
Nosaka, T.,
J. M. van Deursen,
R. A. Tripp,
W. E. Thierfelder,
B. A. Witthuhn,
A. P. McMickle,
P. C. Doherty,
G. C. Grosveld, and J. N. Ihle.
1995.
Defective lymphoid development in mice lacking Jak3.
Science
270:800-802 |
| 16. | Suzuki, M., T. K. Watanabe, T. Fujiwara, Y. Nakamura, E. Takahashi, and A. Tanigami. 1999. Molecular cloning, expression, and mapping of a novel human cDNA, GRP17, highly homologous to human gadd45 and murine MyD118. J. Hum. Genet. 44:300-303[CrossRef][Medline]. |
| 17. | Takekawa, M., and H. Saito. 1998. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95:521-530[CrossRef][Medline]. |
| 18. | Teglund, S., C. McKay, E. Schuetz, J. M. van Deursen, D. Stravopodis, D. Wang, M. Brown, S. Bodner, G. Grosveld, and J. N. Ihle. 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841-850[CrossRef][Medline]. |
| 19. |
Zhan, Q.,
K. A. Lord,
I. Alamo, Jr.,
M. C. Hollander,
F. Carrier,
D. Ron,
K. W. Kohn,
B. Hoffman,
D. A. Liebermann, and A. J. Fornace, Jr.
1994.
The gadd and MyD genes define a novel set of mammalian genes encoding acidic proteins that synergistically suppress cell growth.
Mol. Cell. Biol.
14:2361-2371 |
| 20. | Zhang, W., I. Bae, K. Krishnaraju, N. Azam, W. Fan, K. Smith, B. Hoffman, and D. A. Liebermann. 1999. CR6: a third member in the MyD118 and Gadd45 gene family which functions in negative growth control. Oncogene 18:4899-4907[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»